Lannett Co. Inc. received Food and Drug Administration approval Tuesday to market a generic version of delayed-release Nexium in 20- and 40-milligram dosages.
Nexium, a prescription drug used to treat gastroesophageal reflux disease and other conditions involving excessive stomach acid, was developed by AstraZeneca, a London-based pharmaceutical company that has its U.S. headquarters In Wilmington. Nexium, which contains the active ingredient esomeprazole magnesium, is a second generation version…
Lannett Co. Inc. received Food and Drug Administration approval Tuesday to market a generic version of delayed-release Nexium in 20- and 40-milligram dosages.
Nexium, a prescription drug used to treat gastroesophageal reflux disease and other conditions involving excessive stomach acid, was developed by AstraZeneca, a London-based pharmaceutical company that has its U.S. headquarters In Wilmington. Nexium, which contains the active ingredient esomeprazole magnesium, is a second generation version…